Anders Ingvarsson

Anders Ingvarsson has extensive experience in the biotechnology and diagnostics sectors, currently serving as the Chief Executive Officer and Board Member at LifeAssays AB since February 2011, and as the Chairman of the Board and Chief Executive Officer at Aegirbio since December 2019. Aegirbio specializes in drug monitoring for biological therapies in autoimmune, oncology, and neurology fields. Anders co-founded Ingvarssonconsulting AB, where management consulting in Clinical Diagnostics and Biotechnology was provided from September 2010 to January 2011. Previously, Anders held senior roles in sales and marketing at ExonHit Therapeutics and Sangtec Molecular Diagnostics, and managed analytical development at LKB. Anders holds a Master of Science in Chemical Engineering from KTH Royal Institute of Technology, completed between 1977 and 1981.